AKTX insider transaction filings
Akari Therapeutics Plc — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-19. Screen AKTX transaction legs live →
Insider transaction summary — last 90 days
2026-06-25 to 2026-09-23, from the filings listed below: 5 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Farag Kameel D. — Interim CFO | 3 | — | — | 9 |
| Patel Samir Rashmikant — Director, 10% owner | 1 | — | — | 6 |
| Gaslightwala Abizer — CEO, Director | 1 | — | — | 2 |
Recent Form 4 filings — Akari Therapeutics Plc
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-19 | 4 | Farag Kameel D. — Interim CFO | Grant/award (A): 1,728 @ $7.52 | EDGAR |
| 2026-08-05 | 4 | Farag Kameel D. — Interim CFO | Grant/award (A): 1,130 @ $11.50 | EDGAR |
| 2026-07-17 | 4 | Patel Samir Rashmikant — Director, 10% owner | Option exercise (M): 1,209 @ $8 · Option exercise (M): 15,466 @ $0.00 · Option exercise (M): 5,799 @ $0.00 · Option exercise (M): 1,209 (derivative) @ $32 · Option exercise (M): 15,466 (derivative) @ $16.16 · Option exercise (M): 5,799 (derivative) @ $16.16 | EDGAR |
| 2026-06-25 | 4 | Farag Kameel D. — Interim CFO | Grant/award (A): 1,248 @ $10.02 · Grant/award (A): 1,395 @ $9.32 · Grant/award (A): 1,570 @ $8.28 · Grant/award (A): 2,539 @ $5.12 · Grant/award (A): 3,725 @ $3.49 · Grant/award (A): 7,353 @ $3.74 · +1 more | EDGAR |
| 2026-06-25 | 4 | Gaslightwala Abizer — CEO, Director | Grant/award (A): 5,500 (derivative) @ $0 · Grant/award (A): 15,563 (derivative) @ $0 | EDGAR |
| 2026-03-16 | 4 | Neal James R — Director | Purchase (P): 2,473 (derivative) · Purchase (P): 2,473 (derivative) @ $0.40 · Purchase (P): 3,093 (derivative) · Purchase (P): 3,093 (derivative) @ $0.40 | EDGAR |
| 2025-12-18 | 4 | Prudo-Chlebosz Raymond — Director | Purchase (P): 618,658 (derivative) · Purchase (P): 618,658 (derivative) @ $0.40 · Purchase (P): 386,661 (derivative) · Purchase (P): 386,661 (derivative) @ $0.40 | EDGAR |
| 2025-12-18 | 4 | Patel Sandip I — Director | Purchase (P): 247,462 (derivative) · Purchase (P): 247,462 (derivative) @ $0.40 · Purchase (P): 154,664 (derivative) · Purchase (P): 154,664 (derivative) @ $0.40 | EDGAR |
| 2025-12-18 | 4 | Farag Kameel D. — Interim CFO | Purchase (P): 24,745 (derivative) · Purchase (P): 24,745 (derivative) @ $0.40 | EDGAR |
| 2025-12-18 | 4 | Patel Samir Rashmikant — Director, 10% owner | Purchase (P): 618,658 (derivative) · Purchase (P): 618,658 (derivative) @ $0.40 · Purchase (P): 231,997 (derivative) · Purchase (P): 231,997 (derivative) @ $0.40 | EDGAR |
| 2025-12-18 | 4 | Gaslightwala Abizer — CEO, Director | Purchase (P): 309,328 (derivative) · Purchase (P): 309,328 (derivative) @ $0.40 · Purchase (P): 773,323 (derivative) · Purchase (P): 773,323 (derivative) @ $0.40 | EDGAR |
| 2025-12-18 | 4 | Bazemore Robert B — Director | Purchase (P): 123,731 (derivative) · Purchase (P): 123,731 (derivative) @ $0.40 · Purchase (P): 30,932 (derivative) · Purchase (P): 30,932 (derivative) @ $0.40 | EDGAR |
| 2025-12-18 | 4 | Huh Hoyoung — Director, 10% owner | Purchase (P): 618,658 (derivative) · Purchase (P): 618,658 (derivative) @ $0.40 · Purchase (P): 3,093,293 (derivative) · Purchase (P): 3,093,293 (derivative) @ $0.40 | EDGAR |
| 2025-11-04 | 4 | Farag Kameel D. — Interim CFO | Grant/award (A): 32,000 @ $0.75 · Grant/award (A): 26,619 @ $0.75 | EDGAR |
| 2025-10-24 | 4 | Farag Kameel D. — Interim CFO | Grant/award (A): 6,277 @ $0.74 | EDGAR |
| 2025-08-29 | 4 | Gaslightwala Abizer — CEO, Director | Purchase (P): 10,000 @ $0.94 · Purchase (P): 8,000 @ $0.93 · Purchase (P): 3,000 @ $0.90 | EDGAR |
| 2025-06-25 | 4 | Gaslightwala Abizer — President & CEO, Director | Purchase (P): 943 @ $1.15 · Purchase (P): 5,203 @ $1.16 | EDGAR |
| 2025-06-24 | 4 | Gaslightwala Abizer — President & CEO, Director | Purchase (P): 10,000 @ $1.20 | EDGAR |
| 2025-06-20 | 4 | Gaslightwala Abizer — President & CEO, Director | Purchase (P): 15,000 @ $1.20 | EDGAR |
| 2025-06-16 | 4 | Gaslightwala Abizer — CEO, Director | Grant/award (A): 20,000 @ $1.23 · Grant/award (A): 25,000 @ $1.19 | EDGAR |
| 2025-06-12 | 4 | Gaslightwala Abizer — CEO, Director | Grant/award (A): 20,000 @ $1.27 | EDGAR |
| 2025-04-29 | 4 | Patel Sandip I — Director | Grant/award (A): 44,642 @ $1.12 · Grant/award (A): 44,642 (derivative) @ $1.12 · Grant/award (A): 44,642 (derivative) @ $1.12 | EDGAR |
| 2025-03-24 | 4 | Neal James R — Director | Grant/award (A): 175,000 (derivative) @ $0 · Grant/award (A): 225,000 (derivative) @ $0 | EDGAR |
| 2025-03-24 | 4 | Bazemore Robert B — Director | Grant/award (A): 175,000 (derivative) @ $0 · Grant/award (A): 225,000 (derivative) @ $0 | EDGAR |
| 2025-03-24 | 4 | Patel Samir Rashmikant — Director | Grant/award (A): 175,000 (derivative) @ $0 · Grant/award (A): 225,000 (derivative) @ $0 | EDGAR |
| 2025-03-24 | 4 | Prudo-Chlebosz Raymond — Director | Grant/award (A): 175,000 (derivative) @ $0 · Grant/award (A): 225,000 (derivative) @ $0 | EDGAR |
| 2025-03-24 | 4 | Patel Sandip I — Director | Grant/award (A): 175,000 (derivative) @ $0 · Grant/award (A): 225,000 (derivative) @ $0 | EDGAR |
| 2025-03-24 | 4 | Hombeck Torsten — CFO | Grant/award (A): 300,000 (derivative) @ $0 · Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2025-03-24 | 4 | Gaslightwala Abizer — Director | Grant/award (A): 1,100,000 (derivative) @ $0 · Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2025-03-24 | 4 | Huh Hoyoung — Director, 10% owner | Grant/award (A): 175,000 (derivative) @ $0 · Grant/award (A): 225,000 (derivative) @ $0 | EDGAR |
| 2025-03-10 | 4 | Prudo-Chlebosz Raymond — Director | Grant/award (A): 446,428 @ $1.12 · Grant/award (A): 446,428 (derivative) @ $1.12 · Grant/award (A): 446,428 (derivative) @ $1.12 | EDGAR |
| 2025-03-10 | 4 | Patel Samir Rashmikant — Director | Grant/award (A): 406,250 @ $1.12 · Grant/award (A): 406,250 (derivative) @ $1.12 · Grant/award (A): 406,250 (derivative) @ $1.12 | EDGAR |
| 2025-03-10 | 4 | Neal James R — Director | Grant/award (A): 4,464 @ $1.12 · Grant/award (A): 4,464 (derivative) @ $1.12 · Grant/award (A): 4,464 (derivative) @ $1.12 | EDGAR |
| 2025-03-10 | 4 | Gaslightwala Abizer — Director | Grant/award (A): 133,928 @ $1.12 · Grant/award (A): 133,928 (derivative) @ $1.12 · Grant/award (A): 133,928 (derivative) @ $1.12 | EDGAR |
| 2025-03-10 | 4 | Bazemore Robert B — Director | Grant/award (A): 44,642 @ $1.12 · Grant/award (A): 44,642 (derivative) @ $1.12 · Grant/award (A): 44,642 (derivative) @ $1.12 | EDGAR |
| 2025-03-10 | 4 | Huh Hoyoung — Director, 10% owner | Grant/award (A): 892,857 @ $1.12 · Grant/award (A): 892,857 (derivative) @ $1.12 · Grant/award (A): 892,857 (derivative) @ $1.12 | EDGAR |
| 2025-02-07 | 4/A | Gaslightwala Abizer — Director | Grant/award (A): 11,640 @ $1.22 | EDGAR |
| 2025-01-13 | 4 | Gaslightwala Abizer — Director | Grant/award (A): 11,439 @ $1.22 | EDGAR |
| 2025-01-13 | 4 | Hombeck Torsten — CFO | Grant/award (A): 200 @ $1.22 | EDGAR |
| 2025-01-10 | 4 | Neal James R — Director | Grant/award (A): 8,000,000 @ $0.00 | EDGAR |
| 2025-01-07 | 4 | Gaslightwala Abizer — Director | Grant/award (A): 1,720,000 @ $0.00 | EDGAR |
| 2025-01-07 | 4 | Patel Samir Rashmikant — Director | Grant/award (A): 208,000 @ $0.00 · Grant/award (A): 152,672,000 (derivative) @ $0 | EDGAR |
| 2024-12-30 | 4 | Patel Samir Rashmikant — Director | Grant/award (A): 3,200,000 @ $0.00 · Grant/award (A): 400,000 @ $0.00 | EDGAR |
| 2024-12-30 | 4 | Gaslightwala Abizer — Director | Grant/award (A): 40,000,000 @ $0.00 | EDGAR |
| 2024-12-27 | 4 | Gaslightwala Abizer — Director | Grant/award (A): 30,000,000 @ $0.00 | EDGAR |
| 2024-12-27 | 4 | Patel Samir Rashmikant — Director | Grant/award (A): 7,500,000 @ $0.00 | EDGAR |
| 2024-12-26 | 4 | Patel Samir Rashmikant — Director | Grant/award (A): 1,400,000 @ $0.00 | EDGAR |
| 2024-12-26 | 4 | Patel Samir Rashmikant — Director | Grant/award (A): 1,400,000 @ $0.00 | EDGAR |
| 2024-12-26 | 4 | Neal James R — Director | Grant/award (A): 2,000,000 @ $0.00 | EDGAR |
| 2024-12-03 | 4 | Prudo-Chlebosz Raymond — Director | Grant/award (A): 419,286,000 @ $0.00 · Grant/award (A): 419,286,000 (derivative) @ $0.00 | EDGAR |
Recent 8-K events — Akari Therapeutics Plc
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-02 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-26 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-22 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-17 | 8-K | 3.03 — Material Modification to Rights of Security Holders 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-02 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-12-17 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-16 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-08 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-26 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AKTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →